Comprehensive management of synchronous colorectal liver metastases at a high-volume center: a propensity score-matched analysis - Takeaways - MDSpire

Comprehensive management of synchronous colorectal liver metastases at a high-volume center: a propensity score-matched analysis

  • By

  • Agostino M. De Rose

  • Elena Panettieri

  • Andrea Campisi

  • Viviana Esposito

  • Francesco Belia

  • Maria Vellone

  • Francesco Ardito

  • Felice Giuliante

  • August 21, 2025

  • 0 min

Share

  • 1

    Synchronous colorectal liver metastases (CLM) are increasingly diagnosed due to improved imaging, leading to worse survival outcomes compared to metachronous metastases.

  • 2

    Centralized treatment in high-volume centers is crucial for managing synchronous CLM, ensuring a multidisciplinary approach and better clinical outcomes.

  • 3

    The study analyzed patients undergoing curative-intent liver resection for CLM at a high-volume center from 2010 to 2021, focusing on treatment strategies and outcomes.

  • 4

    Preoperative chemotherapy is indicated for initially unresectable or marginally resectable CLM, with surgical resection performed once resectability is achieved.

  • 5

    The study emphasizes the importance of a coordinated multidisciplinary approach for managing synchronous CLM, regardless of initial referral status.

Original Source(s)

Comprehensive management of synchronous colorectal liver metastases at a high-volume center: a propensity score-matched analysis

  • by Agostino M. De Rose, Elena Panettieri, Andrea Campisi, Viviana Esposito, Francesco Belia, Maria Vellone, Francesco Ardito, Felice Giuliante

  • August 21, 2025

Related Content

Comparative analysis of anal sphincter-preserving surgical techniques in ultra-low rectal cancer

Commentary: Acceptance and commitment therapy combined with usual care improves psychosocial outcomes and reduces complications in patients with permanent colostomies after colorectal cancer surgery: a retrospective cohort study

A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases

Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a hepatic artery infusion (HAI) pump along with standard chemotherapy. Fox Chase is the only local hospital offering this trial, which is designed for patients with colorectal cancer that has spread to the liver and cannot be treated with surgery.

  • by

  • September 13, 2025

  • 3 min